BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35772127)

  • 41. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
    Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
    Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient).
    Pernod G; Joly M; Sonnet B
    J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs.
    Poli D; Antonucci E; Vignini E; Martinese L; Testa S; Simioni P; Pengo V; Pignatelli P; Falanga A; Masciocco L; Barcellona D; Ciampa A; Chiarugi P; Paparo C; Ageno W; Palareti G;
    Eur J Intern Med; 2020 Oct; 80():73-77. PubMed ID: 32522446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracranial hemorrhage and oral anticoagulant treatment.
    Neau JP; Couderq C; Ingrand P; Blanchon P; Gil R;
    Cerebrovasc Dis; 2001; 11(3):195-200. PubMed ID: 11306767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.
    Tsivgoulis G; Katsanos AH; Seiffge DJ; Paciaroni M; Wilson D; Koga M; Macha K; Cappellari M; Kallmünzer B; Polymeris AA; Toyoda K; Caso V; Werring DJ; Engelter ST; De Marchis GM;
    Eur J Neurol; 2020 Aug; 27(8):1612-1617. PubMed ID: 32333493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.
    Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
    Stroke; 2020 Feb; 51(2):416-423. PubMed ID: 31813363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors.
    Miller EJ; Patell R; Uhlmann EJ; Ren S; Southard H; Elavalakanar P; Weber GM; Neuberg D; Zwicker JI
    Blood Adv; 2022 Mar; 6(5):1559-1565. PubMed ID: 35086145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study.
    Grewal K; Atzema CL; Austin PC; de Wit K; Sharma S; Mittmann N; Borgundvaag B; McLeod SL
    Thromb Res; 2022 Jun; 214():47-52. PubMed ID: 35487054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral anticoagulation in patients with chronic kidney disease: A systematic review and meta-analysis.
    Malhotra K; Ishfaq MF; Goyal N; Katsanos AH; Parissis J; Alexandrov AW; Alexandrov AV; Tsivgoulis G
    Neurology; 2019 May; 92(21):e2421-e2431. PubMed ID: 31068485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
    Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.
    Menichelli D; Ronca V; Di Rocco A; Pignatelli P; Marco Podda G;
    Eur J Clin Invest; 2021 Mar; 51(3):e13397. PubMed ID: 32895926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
    Xu WW; Hu SJ; Wu T
    J Zhejiang Univ Sci B; 2017 Jul; 18(7):567-576. PubMed ID: 28681581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants.
    Posch F; Königsbrügge O; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2015 Sep; 136(3):582-9. PubMed ID: 26210891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
    Lin RJ; Green DL; Shah GL
    Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The risk of delayed intracranial hemorrhage with direct acting oral anticoagulants after trauma: A two-center study.
    Barmparas G; Kobayashi L; Dhillon NK; Patel KA; Ley EJ; Coimbra R; Margulies DR
    Am J Surg; 2019 Jun; 217(6):1051-1054. PubMed ID: 30336936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists.
    Cipriano A; Pecori A; Bionda AE; Bardini M; Frassi F; Leoli F; Lami V; Ghiadoni L; Santini M
    Intern Emerg Med; 2018 Oct; 13(7):1077-1087. PubMed ID: 29520701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.
    Murthy SB; Gupta A; Merkler AE; Navi BB; Mandava P; Iadecola C; Sheth KN; Hanley DF; Ziai WC; Kamel H
    Stroke; 2017 Jun; 48(6):1594-1600. PubMed ID: 28416626
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: a meta-analysis of randomized trials.
    Elbadawi A; Shnoda M; Mahmoud K; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):380-388. PubMed ID: 32556105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
    Haykal T; Zayed Y; Deliwala S; Kerbage J; Ponnapalli A; Malladi S; Goranta S; Samji V; Adam S
    Thromb Res; 2020 Oct; 194():57-65. PubMed ID: 32788122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.